AP217A - Injectable parasiticidal composition - Google Patents

Injectable parasiticidal composition Download PDF

Info

Publication number
AP217A
AP217A APAP/P/1990/000216A AP9000216A AP217A AP 217 A AP217 A AP 217A AP 9000216 A AP9000216 A AP 9000216A AP 217 A AP217 A AP 217A
Authority
AP
ARIPO
Prior art keywords
hydrogen
substituted
halogen
composition according
mixture
Prior art date
Application number
APAP/P/1990/000216A
Other languages
English (en)
Other versions
AP9000216A0 (en
Inventor
Walter Oechslein
Jean-Claude Gehret
Ernst Hess
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of AP9000216A0 publication Critical patent/AP9000216A0/xx
Application granted granted Critical
Publication of AP217A publication Critical patent/AP217A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/135—Amines having aromatic rings, e.g. ketamine, nortriptyline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0019—Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/22—Heterocyclic compounds, e.g. ascorbic acid, tocopherol or pyrrolidones
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Dermatology (AREA)
  • Engineering & Computer Science (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Pyridine Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
APAP/P/1990/000216A 1989-10-27 1990-10-26 Injectable parasiticidal composition AP217A (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CH389889 1989-10-27

Publications (2)

Publication Number Publication Date
AP9000216A0 AP9000216A0 (en) 1990-10-31
AP217A true AP217A (en) 1992-09-10

Family

ID=4265876

Family Applications (1)

Application Number Title Priority Date Filing Date
APAP/P/1990/000216A AP217A (en) 1989-10-27 1990-10-26 Injectable parasiticidal composition

Country Status (8)

Country Link
EP (1) EP0425443A1 (de)
JP (1) JPH03161438A (de)
KR (1) KR910007521A (de)
AP (1) AP217A (de)
AU (1) AU632862B2 (de)
CA (1) CA2028536A1 (de)
IE (1) IE903877A1 (de)
ZA (1) ZA908597B (de)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU631259B2 (en) * 1989-12-18 1992-11-19 Ciba-Geigy Ag Formulations of benzoylphenyl ureas for combating ectoparasites
US5290794A (en) * 1992-10-27 1994-03-01 Warner Lambert Co. Soluble calcium lactate antibacterial complexes as non-irritating parenteral forms
IT1290845B1 (it) * 1996-12-12 1998-12-14 Isagro Spa Composizioni per il controllo sistemico di parassiti di animali a sangue caldo
TW480153B (en) * 1997-11-20 2002-03-21 Sumitomo Chemical Co Method to control animal ecto-parasites
US6239112B1 (en) * 1998-07-09 2001-05-29 Merial, Inc. Water miscible macrolide solutions
US8124630B2 (en) 1999-01-13 2012-02-28 Bayer Healthcare Llc ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors
EP2298311B1 (de) 1999-01-13 2012-05-09 Bayer HealthCare LLC Omega-carboxyarylsubstituierte-Diphenyl-Harnstoffe als p38-Kinasehemmer
WO2003068228A1 (en) 2002-02-11 2003-08-21 Bayer Pharmaceuticals Corporation Aryl ureas with angiogenesis inhibiting activity
AU2003209119A1 (en) 2002-02-11 2003-09-04 Bayer Pharmaceuticals Corporation Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors
DK1580188T3 (da) 2002-02-11 2012-02-06 Bayer Healthcare Llc Forbindelser af arylurea som kinaseinhibitorer
UY28213A1 (es) 2003-02-28 2004-09-30 Bayer Pharmaceuticals Corp Nuevos derivados de cianopiridina útiles en el tratamiento de cáncer y otros trastornos.
EP1636585B2 (de) 2003-05-20 2012-06-13 Bayer HealthCare LLC Diaryl-harnstoffe mit kinasehemmender wirkung
ME00294B (me) 2003-07-23 2011-05-10 Bayer Pharmaceuticals Corp Fluoro supstituisana omega-karaboksiaril difenil urea za liječenje i prevenciju bolesti i stanja bolesti

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405644A (en) * 1979-07-14 1983-09-20 Bayer Aktiengesellschaft Medicaments for the treatment of disorders of lipometabolism and their use
EP0093977A1 (de) * 1982-05-11 1983-11-16 Bayer Ag 2,5-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0093976A1 (de) * 1982-05-11 1983-11-16 Bayer Ag 2,4-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0142667A1 (de) * 1983-09-22 1985-05-29 BASF Aktiengesellschaft N-Benzoyl-N'-alkoxyphenylharnstoffe und ihre Verwendung zur Bekämpfung von Insekten und Akariden

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ES2051998T3 (es) * 1988-02-29 1994-07-01 Pfizer Composiciones aumentadoras del flujo transdermal.

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4405644A (en) * 1979-07-14 1983-09-20 Bayer Aktiengesellschaft Medicaments for the treatment of disorders of lipometabolism and their use
EP0093977A1 (de) * 1982-05-11 1983-11-16 Bayer Ag 2,5-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0093976A1 (de) * 1982-05-11 1983-11-16 Bayer Ag 2,4-Dihalogenbenzoyl-(thio)harnstoffe, Verfahren zu ihrer Herstellung und ihre Verwendung als Schädlingsbekämpfungsmittel
EP0142667A1 (de) * 1983-09-22 1985-05-29 BASF Aktiengesellschaft N-Benzoyl-N'-alkoxyphenylharnstoffe und ihre Verwendung zur Bekämpfung von Insekten und Akariden

Also Published As

Publication number Publication date
AU632862B2 (en) 1993-01-14
AP9000216A0 (en) 1990-10-31
KR910007521A (ko) 1991-05-30
IE903877A1 (en) 1991-05-08
CA2028536A1 (en) 1991-04-28
JPH03161438A (ja) 1991-07-11
EP0425443A1 (de) 1991-05-02
ZA908597B (en) 1991-07-31
AU6499890A (en) 1991-05-02

Similar Documents

Publication Publication Date Title
AP217A (en) Injectable parasiticidal composition
US5177110A (en) Injectable parasiticidal composition
EP0546018B1 (de) Florfenicol enthaltendes arzneimittel
EP1610613B1 (de) Topische anthelmintika-formulierungen für den veterinärbereich
CN106474120B (zh) 包含异噁唑啉活性剂的杀寄生物组合物，其方法和用途
EP1713466B1 (de) Antiparasitische zusammensetzung mit einem organischen aminsalz von closantel
EP0137627B1 (de) Aufgiessformulierung gegen Parasiten
EP1551390B1 (de) Formulierung enthaltend Avermectine / Milbemycine und Levamisol in einem Pyrrolidon-Lösungsmittel
NZ248486A (en) Stable anthelmintic formulation containing closantel and one or more avermectins or milbemycins in a glycol based solvent
KR101526285B1 (ko) 동물의 기생충 구제용 약제
JPH05246893A (ja) 水素化ひまし油を含む長期持続性注射製剤
KR20080073700A (ko) 벤즈이미다졸 비수성 조성물
US7094414B2 (en) Famotidine injections
CN1822880B (zh) 杀灭寄生物的组合物
EP0136033A2 (de) Aufgiessformulierung gegen Parasiten
EP0433909A2 (de) Formulierung
AU2005336458B2 (en) Anthelmintic formulations
JPS6242924A (ja) 駆虫剤および殺菌剤組成物
CA2839491A1 (en) Anti-parasitic composition comprising a macrocyclic lactone and levamisole and method of treatment of parasitic infestation
JPH11511479A (ja) １，２，４−ベンゾトリアジンオキシド製剤
IE54131B1 (en) Anthelmintic imidazo (2,1-b) thiazole salts
US11903962B1 (en) Isoxazoline complexes and compositions thereof
JP7523439B2 (ja) 活性医薬成分の安定性向上のための製剤、方法、ｋｉｔ、及び剤形
AU2002100152B4 (en) Parasiticide composition
RU2660353C2 (ru) Способ и улучшенная фармацевтическая композиция для ускорения трансдермальной доставки ингибитора pde-5